Abstract

Birth of a Future Giant: Zoom on the Chinese Microfluidics Industry

Sébastien Clerc, Market & Technology Analyst, Yole Développement

The Chinese government has created a strategic plan to comprehensively upgrade the country’s industrial sector and make China a major player that is independent from other countries. This plan, “Made in China 2025”, includes a focus on pharmaceuticals and medical devices. Companies involved in these sectors will benefit from almost unlimited funding by 2025, with the goal to compete with foreign industries and retake significant market share. As a key tool for diagnostics and life sciences applications, microfluidic technology will surely benefit from this massive spend.

As a consequence, in the recent years, many microfluidic companies were created in China and are now bringing some products to the market. But which are these companies, what is their position in the supply chain, what are their capabilities and are they a threat to foreign companies? What are the opportunities for Western companies in China? Yole’s presentation will provide an overview of the Chinese microfluidics landscape and explain how this may evolve in the next few years, highlighting the threats and opportunities for foreign players.